Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 0.00% is 100% below its 5-year average of 52.58%, near the low end of its 5-year range (0.00%–134.89%).
As of the fiscal period ended Tuesday, June 30, 2026. 100.00% below its 12-month average of 16.50%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
DEBT TO ASSETS RATIO
0.00%
DEBT TO ASSETS RATIO AVG TTM
16.50%
DEBT TO ASSETS RATIO AVG 3Y
45.34%
DEBT TO ASSETS RATIO AVG 5Y
52.58%
DEBT TO ASSETS RATIO AVG 10Y
16.44%
DEBT TO ASSETS RATIO AVG 15Y
7.90%
DEBT TO ASSETS RATIO AVG 20Y
0.00%
CURRENT VS TTM AVG
-100.00%
CURRENT VS 3Y AVG
-100.00%
CURRENT VS 5Y AVG
-100.00%
CURRENT VS 10Y AVG
-100.00%
CURRENT VS 15Y AVG
-100.00%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.10%
median of 586 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Fennec Pharmaceuticals Inc.
Market Cap
$355.01M
Debt to Assets Ratio
0.00%
TTM Avg
16.50%
3Y Avg
45.34%
5Y Avg
52.58%
Market Cap
$349.81M
Debt to Assets Ratio
0.19%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$349.67M
Debt to Assets Ratio
0.38%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$343.16M
Debt to Assets Ratio
0.03%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$370.95M
Debt to Assets Ratio
0.25%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$374.50M
Debt to Assets Ratio
0.15%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$377.74M
Debt to Assets Ratio
0.10%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Fennec Pharmaceuticals Inc. (FENC) | $355.01M | 0.00% | 16.50% | 45.34% | 52.58% |
| Embecta Corp. (EMBC)vs › | $350.33M | 1.19% | N/A | N/A | N/A |
| Enanta Pharmaceuticals, Inc. (ENTA)vs › | $349.81M | 0.19% | N/A | N/A | N/A |
| Opus Genetics, Inc. (IRD)vs › | $349.67M | 0.38% | N/A | N/A | N/A |
| Artiva Biotherapeutics, Inc. (ARTV)vs › | $343.16M | 0.03% | N/A | N/A | N/A |
| Canopy Growth Corporation (CGC)vs › | $370.95M | 0.25% | N/A | N/A | N/A |
| Agenus Inc. (AGEN)vs › | $338.15M | 0.24% | N/A | N/A | N/A |
| Kyverna Therapeutics, Inc. (KYTX)vs › | $374.50M | 0.15% | N/A | N/A | N/A |
| Arcturus Therapeutics Holdings Inc. (ARCT)vs › | $377.74M | 0.10% | N/A | N/A | N/A |
| ClearPoint Neuro, Inc. (CLPT)vs › | $330.19M | 0.74% | N/A | N/A | N/A |
Debt/Assets
0.0%
Debt/Equity
0.00
Current Ratio
5.85
Interest Coverage
-3.0x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 39.34% |
| 2025-06-30 | 43.15% |
| 2025-03-31 | 41.70% |
| 2024-12-31 | 43.03% |
| 2024-09-30 | 54.48% |
| 2024-06-30 | 50.33% |
| 2024-03-31 | 45.33% |
| 2023-12-31 | 115.22% |
| 2023-09-30 | 134.89% |
| 2023-06-30 | 130.61% |
| 2023-03-31 | 115.21% |
| 2022-12-31 | 92.43% |
| 2022-09-30 | 81.17% |
| 2022-06-30 | 32.05% |
| 2022-03-31 | 26.05% |
| 2021-12-31 | 22.25% |
| 2021-09-30 | 19.17% |
| 2021-06-30 | 17.73% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 0.00% |
| 2013-09-30 | 0.00% |
| 2013-06-30 | 0.00% |
| 2013-03-31 | 0.00% |
| 2012-12-31 | 0.00% |
| 2012-09-30 | 0.00% |
| 2012-06-30 | 0.00% |
| 2012-03-31 | 0.00% |
| 2011-12-31 | 0.00% |
| 2011-09-30 | 0.00% |
| 2011-06-30 | 0.00% |
| 2011-03-31 | 0.00% |
| 2010-12-31 | 0.00% |
| 2010-09-30 | 0.00% |
| 2010-06-30 | 0.00% |
| 2010-03-31 | 0.00% |
| 2009-12-31 | 0.00% |
| 2009-09-30 | 0.00% |
| 2009-06-30 | 0.00% |
| 2009-03-31 | 0.00% |
| 2008-12-31 | 0.00% |
| 2008-09-30 | 0.00% |
| 2008-06-30 | 0.00% |
| 2008-03-31 | 0.00% |
| 2007-12-31 | 0.00% |
| 2007-09-30 | 0.00% |
| 2007-06-30 | 0.00% |
| 2007-03-31 | 0.00% |
| 2006-12-31 | 0.00% |
| 2006-09-30 | 0.00% |
| 2006-06-30 | 0.00% |
| 2006-03-31 | 0.00% |
| 2005-12-31 | 0.00% |
| 2005-09-30 | 0.00% |
| 2005-06-30 | 0.00% |
| 2005-03-31 | 0.00% |
| 2004-12-31 | 0.00% |
| 2004-09-30 | 0.00% |
| 2004-06-30 | 0.00% |
| 2004-03-31 | 0.00% |
| 2003-12-31 | 0.00% |
| 2003-09-30 | 0.72% |
| 2003-06-30 | 0.00% |
| 2003-03-31 | 0.62% |
| 2002-12-31 | 0.00% |
| 2002-09-30 | 1.00% |
